Beskrovnaya Oxana

Chief Scientific Officer | See Remarks

1 company

Good

Trades Analyzed

12M Win Rate

54.2%

Avg 3M Return

-5.9%

Avg 12M Return

-7.6%

Beskrovnaya Oxana is a Chief Scientific Officer at Dyne Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 13 sells.

Estimated insider holdings value: $4.0M based on current market prices.

Holdings by Company

DYNMar 11, 2025

Current Shares195.8K

Value$4.04M

Net Activity-155,766

Bought: 0Sold: 155.8K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 11, 2025	DYN Dyne Therapeutics, Inc.	Chief Scientific Officer	Sell	2,153	$11.38	$24,501.14	-1.1%	+19.7%	+66.2%
Mar 5, 2025	DYN Dyne Therapeutics, Inc.	Chief Scientific Officer	Sell	1,094	$11.83	$12,942.02	-0.5%	+8.9%	+24.8%
Feb 18, 2025	DYN Dyne Therapeutics, Inc.	Chief Scientific Officer	Sell	2,598	$13.95	$36,242.10	-1.3%	-15.4%	+11.6%
Dec 11, 2024	DYN Dyne Therapeutics, Inc.	Chief Scientific Officer	Sell	2,334	$28.12	$65,632.08	-1.1%	-56.2%	-29.3%
Nov 18, 2024	DYN Dyne Therapeutics, Inc.	Chief Scientific Officer	Sell	2,856	$28.20	$80,539.20	-2.0%	-53.0%	-28.6%
Sep 18, 2024	DYN Dyne Therapeutics, Inc.	Chief Scientific Officer	Sell	2,339	$34.55	$80,812.45	-1.6%	-23.8%	-59.5%
Sep 11, 2024	DYN Dyne Therapeutics, Inc.	Chief Scientific Officer	Sell	2,161	$31.89	$68,914.29	-1.5%	-13.1%	-59.6%
Aug 19, 2024	DYN Dyne Therapeutics, Inc.	Chief Scientific Officer	Sell	2,636	$45.12	$118,939.40	-0.9%	-36.4%	-73.4%
Jun 11, 2024	DYN Dyne Therapeutics, Inc.	Chief Scientific Officer	Sell	2,136	$31.34	$66,942.24	-1.4%	+4.9%	-52.9%
May 20, 2024	DYN Dyne Therapeutics, Inc.	Chief Scientific Officer	Sale+OE	30,426	$32.96	$1,002,751.23	-6.2%	+30.4%	-65.1%